What are the most important changes in the 2019 ESC/EAS Dyslipidemia Guidelines? - PACE-CME

What are the most important changes in the ESCEAS Dyslipidemia Guidelines

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Biochemical urine test to measure medical adherence in hypertension
Biochemical urine test to measure medical adherence in hypertension
ESC 2019
Biochemical urine test to measure medical adherence in hypertension
Hs-troponin measured 30 min after admission to diagnose MI
Hs-troponin measured 30 min after admission to diagnose MI
ESC 2019
Hs-troponin measured 30 min after admission to diagnose MI
- Camilla Bang, MD
Betablocker use associated with reduced mortality in HFrEF patients >80 years
Betablocker use associated with reduced mortality in HFrEF patients >80 years
ESC 2019
Betablocker use associated with reduced mortality in HFrEF patients >80 years
- Gianluigi Savarese, MD
NP metabolism associated with clinical outcomes in HF
NP metabolism associated with clinical outcomes in HF
ESC 2019
NP metabolism associated with clinical outcomes in HF
- Frank Gommans, MD, PhD